期刊文献+

ERK1/2参与IL-33诱导的心脏成纤维细胞增殖和纤维化过程

ERK1/2 is involved in the process of IL-33-induced proliferation of CFBs and fibrosis
下载PDF
导出
摘要 目的探讨ERK1/2通路在IL-33激活心脏成纤维细胞中的表达及其作用。方法培养心脏成纤维细胞,10 ng/m L IL-33刺激细胞,不同时间点MTT法检测IL-33对心脏成纤维细胞增殖的影响;RT-PCR检测细胞标志性基因α-SMA及通路关键分子TRAF-6的m RNA表达水平;Western blot检测α-SMA、TRAF-6及p-ERK1/2和ERK1/2的蛋白表达。结果 IL-33能促进心脏成纤维细胞的增殖(P<0.05);IL-33刺激细胞24h,TRAF-6表达显著上调(P<0.05),p-ERK1/2蛋白水平表达明显高于对照组(P<0.05);IL-33干预24h后α-SMA表达明显上调(P<0.05),ERK1/2特异性阻断剂PD98059可有效抑制该效应。结论ERK1/2通路参与了IL-33诱导的心脏成纤维细胞增殖和纤维化过程。 Objective To explore the role of ERK1/2 in the process of IL-33-induced activation of CFBs. Methods Culturing and stimulating CFBs cells with 10 ng/m L IL-33 at different time points, the proliferation of CFBs cells was tested by MTT; RT-PCR detected changes of genes α-SMA m RNA and critical signal transducer TRAF-6 m RNA;Western blotting was used to test the protein expression of α-SMA、TRAF-6、p-ERK1/2 and ERK1/2. Results The data showed that IL-33 had an effect on proliferation of CFBs cells(P0.05); After CFBs were treated for 24 h, the expression of TRAF-6 was up-regulated(P0.05) and the protein level of p-ERK1/2 was significantly increased(P0.05);Treatment cells with IL- 33 for 24 h the expression of α- SMA was up- regulated( P 0. 05), but ERK1 / 2 inhibitor PD98059 significantly abrogated the effect of IL-33. Conclusion The activation of ERK1/2 signaling pathway might be involved in the process of IL-33-induced proliferation of CFBs and fibrosis.
出处 《中国现代医生》 2014年第34期4-7,共4页 China Modern Doctor
基金 浙江省宁波市自然科学基金资助项目(2014A610276 2014A610271)
关键词 IL-33/ST2信号通路 ERK1/2 心脏成纤维细胞 IL-33/ST2 signaling pathway ERK1/2 Cardiac fibroblasts
  • 相关文献

参考文献17

  • 1王禹川,丁燕生,刘梅林.不同因子致心肌纤维化分子学机制[J].医学综述,2012,18(17):2736-2740. 被引量:34
  • 2Marchant DJ,Boyd JH,Lin DC,et al. Inflammation in my- ocardial[J]. Circ Res,2012,110( 1 ) : 126-144. 被引量:1
  • 3张晓歌,陶小玲,张贤锐,苏立.PLGF参与Ang Ⅱ诱导的心脏成纤维细胞激活[J].中国病理生理杂志,2013,29(4):603-608. 被引量:7
  • 4Zhu J, Carver W. Effects of interleukin-33 on cardiac fi- broblast gene expression and activity[J]. Cytokine,2012, 58(3) :368-379. 被引量:1
  • 5Miller AM, Liew FY. The IL-33/ST2 pathway-A new ther- apeutic target in cardiovascular disease[J]. Pharmacol Ther, 2011,131 (2) :179-186. 被引量:1
  • 6Garg A,Akoum N. Atrial fibrillation and heart failure:Be- yond the heart rate [J]. Curr Opin Cardiol, 2013,28 (3) : 332-336. 被引量:1
  • 7李萌,吕仕超,吴美芳,张军平.不同原因诱导的心肌纤维化动物模型的建立[J].医学研究生学报,2014,27(3):330-334. 被引量:16
  • 8Xu X,Ding F,Pang J,et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat[J]. Am J Physiol Heart Circ Physiol,2012, 303(6) :703-711. 被引量:1
  • 9Carnevale D,Lembo G. Placental growth factor and car- diac inflammation[J]. Trends Cardiovasc Med,2012,22(8) : 209-212. 被引量:1
  • 10Rui T, Zhang J, Xu X, et al. Reduction in IL-33 ex- pression exaggerates ischaemia/reperfusion-induced myo- cardial injury in mice with diabetes mellitus[J]. Cardiovasc Res,2012, 94(2) :370-378. 被引量:1

二级参考文献50

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部